Psychotic Disorders  >>  GSK1034702  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK1034702 / GSK
NCT01371799: A Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy Smokers

Completed
1
9
Europe
Drug
GlaxoSmithKline
Mental Disorders
06/10
06/10

Download Options